Arnaud Marchand
44Patents
6h-index
53Co-inventors
72Inventor score
Filing activity: Aug 27, 2004 → May 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8889711B2 | Pyrazolopyridine derivatives as anticancer agent | Chemistry; Metallurgy | 46 | Active |
| US10029984B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US10117850B2 | Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 20 | Active |
| US9944598B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US7501513B2 | Immunosuppressive effects of pteridine derivatives | Chemistry; Metallurgy | 17 | Expired |
| US10206902B2 | Mono- or di-substituted indoles as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US9266832B2 | Compounds for the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 6 | Active |
| US11851422B2 | Anti-viral compounds | Chemistry; Metallurgy | 6 | Active |
| US10689340B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US8785638B2 | Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8906906B2 | Viral replication inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8618138B2 | Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 3 | Active |
| US10550123B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10696632B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10919854B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US12065428B2 | Anti-viral compounds | Chemistry; Metallurgy | 1 | Active |
| US12209081B2 | Heterocycle derivatives for treating TRPM3 mediated disorders | Chemistry; Metallurgy | 1 | Active |
| US11827602B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9434722B2 | Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 1 | Active |
| US11952365B2 | Anti-viral compounds | Chemistry; Metallurgy | 1 | Active |
| US11180450B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11407715B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10730884B2 | Substituted indole compound derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10913716B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10646469B2 | Substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.